MedPeer Co., Ltd. Sunday, October 16, 2022 MedPeer and 4DIN hold a session on the theme of “real world dat a” at the 15th IT Healthcare Society Annual Conference

MedPeer Inc.
[Sunday, October 16, 2022] MedPeer and 4DIN hold a session on the theme of “real world data” at the 15th IT Healthcare Society Annual Conference
Introduces how to use the data of “physician’s insight data” and “electronic medical record data” that contribute to the improvement of medical technology and problem solving, with examples

MedPeer Co., Ltd. (Chuo-ku, Tokyo, President and CEO: Yo Iwami, hereinafter: Medpia) and 4DIN Co., Ltd. (Minato-ku, Tokyo,
Representative Director: Akihiko Takahashi, hereinafter: 4DIN) announced on October 15, 2022 ( At the “15th IT Healthcare Society Annual Conference” to be held from Saturday to 16th (Sunday), the title was “Updates on the use of real world data – New value provided by the use of electronic medical record data -” The sponsored session will be held from 10:40 on the 16th (Sunday), the second day of the conference.
In this session, 4DIN will explain how 4DIN utilizes real-world data (hereinafter referred to as RWD (*)) of approximately 5 million people, centered on hospital electronic medical record data. In addition, how to return the analysis results of doctors’ “insight data” and “RWD” accumulated through the operation of the doctor community platform “MedPeer” in which 150,000 doctor members participate to the medical field, patients, and society. We will consider how to proceed.
In recent years, with the advancement of IT technology, the
utilization of “big data”, which accumulates enormous amounts of data, is being promoted in various fields. In the medical and health fields as well, “RWD”, which accumulates information based on clinical practice obtained in clinical settings, such as individual medical history, treatment history, and medications taken, is used to improve the quality and efficiency of medical care and research and
development. Expectations are high that it will be useful for On the other hand, the specifications of electronic medical records are not unified among medical institutions, and from the viewpoint of privacy protection, there are high hurdles to building versatile and extensive data, and its utilization has not progressed sufficiently. did.
However, in recent years, due to the development of anonymization technology, it has become possible for medical institutions such as university hospitals and private companies to appropriately and easily utilize the medical data necessary for research and development in a privacy-friendly manner. I came. Furthermore, by structuring and standardizing data in different formats, it becomes possible to integrate and use information accumulated by different medical institutions, thereby facilitating and revitalizing disease research and treatment development. is expected.
In this session, we will focus on doctors’ “insight data” and “electronic medical record data” among RWD, which has been attracting attention in recent years. We will introduce the method with examples. We hope that this information will help doctors who are interested in the future potential of RWD and how to utilize it.
* Real World Data (RWD): A general term for medical data generated from daily clinical settings. Information on patients and medical practices obtained outside of clinical trials, such as health checkup data, DPC data, electronic medical record data, and data obtained from wearable devices.
■Outline of conference/sponsored session
[Table 2: ]
* 4DIN will also have a “Corporate Exhibition”.
Building 1, Makuhari Campus, Toto University 1-1 Hibino, Mihama Ward, Chiba City, Chiba Prefecture 261-0021
[Profile of speakers (titles omitted)]
[Image 1

● MedPeer Co., Ltd. Medical Business Division Yoshitane Yusa In my previous job, I worked in the healthcare department of a foreign-affiliated consulting company specializing in actuarial science, with pharmaceutical companies and medical device companies as my main clients, and supported the analysis and publication of RWD. Joined MedPeer in June 2022 and is promoting a business that creates value by fusing RWD and MedPeer’s insight data.

[Image 2

● 4DIN Co., Ltd. CEO Akihiko Takahashi
After completing a master’s degree at the University of Hawaii, joined Convergence CT, Inc. (Hawaii, USA), a venture company that collects and analyzes medical data and uses it for the efficient development and supply of pharmaceuticals. As Representative Director of subsidiary Convergence CT Japan Co., Ltd. (CCTJ), he is in charge of launching the Japanese market. In 2019, MBO of CCTJ was implemented and 4DIN was established. Appointed representative director.

[Image 3

●University of Hawaii Cancer Center/Sapporo Heart Center
Epidemiology expert Yuhito Okada
A U.S. epidemiologist who trained at the CDC and worked as a field epidemiologist in Africa, the Middle East, and Asia, she is currently working in the Department of Cancer Epidemiology at the University of Hawaii Cancer Center, specializing in racial cancer incidence. Researching cancer epidemiology related to treatment. In a
multi-ethnic cohort study, we are comprehensively analyzing everything from genes to lifestyle using AI. Hawaii State Government COVID-19 Response Team
[Outline of MedPeer Co., Ltd.]
Company name: MedPeer Co., Ltd.
Location: 9th floor, Ginza Shochiku Square, 1-13-1 Tsukiji, Chuo-ku, Tokyo Established: December 2004
Representative: Yo Iwami, President and CEO (Physician, Doctor of Medicine) Business: Operation of MedPeer, a community site dedicated to doctors, and other related businesses
[Overview of 4DIN Co., Ltd.]
Company name: 4DIN Co., Ltd.
Location: 2-20-15 Shimbashi, Minato-ku, Tokyo Shimbashi Ekimae Building No. 1 Building 805
Established: June 2003
Representative: Representative Director Akihiko Takahashi
Business Activities: Research and development of pharmaceuticals and quasi-medical products, and outsourcing of these operations
    Contracting clinical testing
Provision and analysis of data related to the development and clinical testing of pharmaceuticals and quasi-medical products
     Consulting on the development and clinical testing of
pharmaceuticals and quasi-medical products

Details about this release:


One thought on “MedPeer Co., Ltd. Sunday, October 16, 2022 MedPeer and 4DIN hold a session on the theme of “real world dat a” at the 15th IT Healthcare Society Annual Conference

  1. Bentyl side effects. fast or slow heartbeats, pounding heartbeats or fluttering in your chest;
    confusion, agitation, hallucinations, unusual thoughts or behavior.

Leave a Reply

Your email address will not be published.

%d bloggers like this: